Latest: FDA Approves New Biosimilar for Oncology Treatment

STAT+: GLP-1s, cancer care are driving higher employer health care costs in 2026

0 Mins
Health care costs are set to jump again next year, creating a challenge for employers.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago